Applied Molecular Transport Appoints Holly Schachner, M.D. to its Board of Directors
August 24, 2021 16:01 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 24, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the appointment of...
Applied Molecular Transport Reports Second Quarter 2021 Financial Results and Provides Corporate Update
August 10, 2021 16:01 ET
|
Applied Molecular Transport Inc.
Top-line data readouts expected from four Phase 2 trials of oral AMT-101, consistent with previous guidance Combination trial of AMT-101 with anti-TNFα in moderate-to-severe ulcerative colitis (UC)...
Applied Molecular Transport to Present at Canaccord Genuity’s 41st Annual Growth Conference
August 05, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Presents Additional Positive Data from Oral AMT-101 Phase 1b in Ulcerative Colitis at ECCO ‘21 Virtual Congress
July 09, 2021 08:00 ET
|
Applied Molecular Transport Inc.
Once daily, oral AMT-101 was safe and well tolerated, and demonstrated trends of improvement in objective measures of inflammation: fecal calprotectin, CRP, and histology Key findings support oral...
Applied Molecular Transport to Present at JMP Securities Life Sciences Conference
June 09, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., June 09, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport to Present at Jefferies Virtual Healthcare Conference
May 26, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., May 26, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Reports First Quarter 2021 Financial Results and Provides Corporate Update
May 13, 2021 16:01 ET
|
Applied Molecular Transport Inc.
Enrollment ongoing in each of oral AMT-101’s four Phase 2 trials On track to announce oral AMT-101 top-line data readouts from the four Phase 2 trials, being conducted in multiple ulcerative colitis...
Applied Molecular Transport to Present at BofA Securities 2021 Health Care Conference
May 06, 2021 08:00 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced that Tahir Mahmood,...
Applied Molecular Transport Announces Closing of Public Offering and Full Exercise of the Underwriters’ Option to Purchase Additional Shares
April 06, 2021 16:01 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., April 06, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the closing of its...
Applied Molecular Transport Announces Pricing of Public Offering of Common Stock
March 31, 2021 20:45 ET
|
Applied Molecular Transport Inc.
SOUTH SAN FRANCISCO, Calif., March 31, 2021 (GLOBE NEWSWIRE) -- Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the pricing of an...